Theriva Biologics, Inc. Adjustment of Warrants Granted for Services
Theriva Biologics, Inc. (TOVX) reported Adjustment of Warrants Granted for Services of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2020-02-20
- Theriva Biologics, Inc. adjustment of warrants granted for services for the quarter ending 2019-12-31 was $0.00.
- Theriva Biologics, Inc. adjustment of warrants granted for services for the quarter ending 2019-09-30 was $0.00.
- Theriva Biologics, Inc. adjustment of warrants granted for services for the quarter ending 2019-06-30 was $0.00.
- Theriva Biologics, Inc. adjustment of warrants granted for services for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. adjustment of warrants granted for services for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Theriva Biologics, Inc. adjustment of warrants granted for services for fiscal 2018 was $9.00K.
- Theriva Biologics, Inc. adjustment of warrants granted for services for fiscal 2017 was $0.00.
| Period end | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 9 month | Adjustment of Warrants Granted for Services 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $0.00 derived: sum of 3 quarters · filed 2020-02-20 | $0.00 10-K · filed 2020-02-20 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | $0.00 derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-02-20 | $0.00 derived: sum of 4 quarters · filed 2020-02-20 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $0.00 derived: sum of 3 quarters · filed 2020-02-20 | $0.00 derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $0.00 derived: sum of 3 quarters · filed 2020-02-20 | $9.00K 10-K · filed 2020-02-20 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $9.00K 10-Q · filed 2019-11-04 | $9.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $9.00K 10-Q · filed 2019-08-08 | $9.00K derived: sum of 3 quarters · filed 2019-08-08 | $9.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $9.00K 10-Q · filed 2019-05-08 | $9.00K derived: sum of 2 quarters · filed 2019-05-08 | $9.00K derived: sum of 3 quarters · filed 2019-05-08 | $9.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $0.00 derived: sum of 3 quarters · filed 2019-02-27 | $0.00 10-K · filed 2019-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |